logo
Valley fever cases are expected to spike in California. Here's how locals, hikers and tourists can avoid it

Valley fever cases are expected to spike in California. Here's how locals, hikers and tourists can avoid it

Yahoo7 days ago

For the second year in a row, California is on track to have a record-breaking number of valley fever cases, which public health officials say are driven by longer, drier summers.
There have been more than 4,000 cases of valley fever reported statewide from January to April, an increase of more than 3,000 cases compared with the same period in 2024 and 2,000 more cases than in 2023, according to the California Department of Public Health.
Last year's recording breaking number of cases reached a total of 12,605; in 2023 there were more than 9,000 cases.
Valley fever, or coccidioidomycosis, is a lung infection that people get when they breathe in spores of the fungus, coccidioides, that lives in dry soil, according to the Centers for Disease Control and Prevention.
Spores of the fungus that grow in the dry soil are released into the air when the soil is disturbed by wind, construction and other activities.
The fungus is found in the Pacific Northwest and Southwest United States, parts of Mexico, Central America and South America.
Last year in Kern County, the music festival Lightning in a Bottle became a hot spot for the disease after 19 people reported contracting valley fever, with several people experiencing severe symptoms, including pneumonia-like conditions, rashes, headaches and exhaustion.
Valley fever cases commonly increase statewide in late summer and decline in the winter, however state public health officials say the onset of valley fever transmission is starting earlier and lasting longer.
Read more: Pasadena resident tests positive for whooping cough after visiting children's museum
UC Berkeley researchers say climate change is expected to lead to drier spring and fall seasons and heavier winter rains. The prolonged dry seasons can extend the periods of high-risk exposure to valley fever.
Valley fever is often misdiagnosed because the symptoms (cough, fever and chest pains) are similar to other infectious diseases, which can make it difficult for health officials to accurately report the number of cases.
The number of valley fever cases so far this year is trending toward a new record but public health officials say it's still too early in the year to determine whether this will be a record breaker.
Here are some precautions to help locals, hikers and tourists in counties with high numbers of reported valley fever cases to avoid the disease this summer.
Public health officials in Fresno County, which includes a section of the John Muir Trail, share the following cautionary tips for hikers:
Stay on well-maintained trails and avoid activities that kick up dust such as digging or biking off-path.
Consider wearing a properly fitted N95 mask when hiking in dusty or dry conditions.
Avoid hiking during windy days or right after a disturbance that may increase dust in the air.
Clean any skin wounds well with soap and water, especially if they have been exposed to soil or dust.
For anyone who lives, works or travels in an area where valley fever fungus grows, the CDC recommends:
Stay indoors when it's windy outside and the air is dusty.
On windy days, keep windows and doors closed to prevent dust and possible spores from entering the home.
When driving through a dusty area, keep car windows closed and use recirculating air, if possible.
Before digging, wet down soil and dirt to prevent stirring up dust into the air.
Consider wearing a properly fitted N95 mask if you must be in dusty air outdoors in these areas.
Read more: Deadly, drug-resistant fungus CDC calls 'urgent threat' is spreading in hospitals
Those who spend a lot of time outdoors and are exposed to dirt and dust in areas where valley fever is common are more likely to contract the disease, according to the Los Angeles County Department of Public Health. That includes construction workers, farmers, military workers and archaeologists.
People who live and work near dry and dusty areas are also at risk of being exposed to valley fever.
People who have an increased risk of contracting the disease include:
Adults 60 years and older.
Those who have diabetes or health conditions that weaken the immune system, which include cancer, HIV, autoimmune illnesses, those with an organ transplant or who are receiving chemotherapy or steroids.
Pregnant women, especially those in the later stages of pregnancy.
Children who are 5 years old and younger.
Those who are of Black, Latino, Native American or Filipino decent, although experts say they don't have a clear answer on why these groups of people are more susceptible.
The fungus infects the lungs and can cause respiratory symptoms that include:
Cough
Fever
Chest pain
Fatigue
Difficulty breathing
Muscle or joint pain
Night sweats
Weight loss
Rash
While Valley fever shares many of the same symptoms as other respiratory diseases, including COVID-19, it takes about one to three weeks for valley fever symptoms to develop, and the illness can last a month or more.
Read more: SoCal officials unleash sterile mosquitoes in bid to curb disease — with promising results
Some people with valley fever may experience only mild symptoms that get better in a few weeks so treatment won't be necessary, according to Los Angeles County public health officials.
However, there are others who will have symptoms that last a month or longer and may need treatment depending on their doctor's consultation.
In rare severe cases, the disease can spread from the lungs to other parts of the body.
The disease is usually diagnosed with a blood test.
If you test negative for COVID-19 and have respiratory symptoms that last more than a week, and live in or have recently traveled to an area where valley fever is more common, public health officials suggest you talk to a doctor.
Because valley fever affects each person differently, treatment will be determined based on the severity of the disease. The disease is often treated with antifungal medications.
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
This story originally appeared in Los Angeles Times.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What Are the Complications and Long-Term Risks of Meningitis
What Are the Complications and Long-Term Risks of Meningitis

Health Line

timean hour ago

  • Health Line

What Are the Complications and Long-Term Risks of Meningitis

Meningococcal meningitis can lead to serious complications, such as hearing loss, scarring, or even amputation. Getting treatment early can prevent these outcomes. Meningitis is a condition characterized by swelling of the lining of the brain and spinal cord. It can be caused by viruses, bacteria, or fungi. Meningococcal meningitis occurs when the bacterium Neisseria meningitidis infects the meninges (tissues around the brain and spinal cord). Neisseria meningitidis can also infect the bloodstream. Meningococcal meningitis and bloodstream infections are two common types of meningococcal disease. An infection of the meninges can cause a dangerous buildup of pressure on the brain. Symptoms of infection may include: headache stiff neck confusion sensitivity to light high fever nausea skin rash vomiting Main complications of meningitis Meningococcal disease is fatal in about 10 to 15 people out of every 100 receiving a diagnosis, according to the Centers for Disease Control and Prevention (CDC). The disease may lead to long-term complications in about 20% of those with the condition. Among the possible complications of meningococcal disease are: chronic pain scarring amputation hearing impairment vision impairment motor function impairment post-infection inflammatory syndromes arthritis post-traumatic stress disorder (PTSD) anxiety depression Some complications of meningococcal disease that require immediate medical attention are: septic shock seizures purpura fulminans (skin rash and possible organ failure) hydrocephalus (fluid buildup on the brain) cerebral venous sinus thrombosis (stroke) Waterhouse-Friderichsen syndrome (bleeding into the adrenal glands) subdural empyema (pus between layers of the brain's protective tissue) Bacteremia and septicemia One type of meningococcal disease is an infection of the tissues around the brain and spinal cord (meningococcal meningitis). Neisseria meningitidis can also infect the bloodstream, resulting in bacteremia or septicemia. Meningococcal septicemia is a dangerous form of bloodstream infection. The bacteria multiply and release toxins that can damage blood vessel linings. Bleeding into the skin or organs may occur. A characteristic dark purple rash may develop in the later stages. Other symptoms may include: fatigue vomiting cold hands and feet chills diarrhea rapid breathing severe aches or pains in the muscles, joints, chest, or belly. This form of infection also requires immediate care and can cause some of the most serious complications of meningococcal disease, such as: necrosis (skin death) hearing loss deafness seizures amputation skin scarring impaired blood flow to the organs heart failure Diagnosis and treatment Diagnosing meningococcal disease can be a challenge because early symptoms look like other conditions. When a doctor suspects meningococcal disease, they can test for the presence of bacteria in cerebrospinal fluid or blood. Getting a sample of spinal fluid requires a lumbar puncture procedure. Antibiotics are the mainstay of treatment. Doctors typically start antibiotic treatment as soon as they suspect meningococcal disease to reduce the risk of serious complications. In some cases, someone with meningococcal disease will require hospitalization. Some types of care they might receive include: intensive care unit (ICU) admission and medications to help maintain a stable blood pressure, especially if it drops too low due to severe infection intravenous (IV) fluids and rehydration breathing and airway support blood transfusions wound and skin care How common are meningitis outbreaks? According to the CDC, there were 438 confirmed and probable cases of meningococcal disease in the United States in 2023. The recent rise in cases has been mostly linked to the serogroup Y strain of Neisseria meningitidis, one of several strains that can cause meningococcal disease. Serogroup Y has been spreading more frequently in recent years, contributing to localized outbreaks. Some groups are more at risk than others. Infants, teens, and young adults tend to have higher rates of developing an infection, as do people with certain medical conditions or those living in close quarters like college dorms or military barracks. Outbreaks also tend to occur in communities with lower vaccination rates or limited access to preventive care. That's why it's so important to recognize the signs, respond quickly to symptoms, and stay up to date with recommended vaccines, especially for people at a higher risk. Vaccines are available that help protect against different types of meningococcal disease, including the strains most often linked to outbreaks, such as serogroups A, C, W, Y, and B.

Lieff Cabraser & Farella Braun + Martel Announce That University of California Researchers Have Filed a Class Action Lawsuit Against the Trump Administration for the Illegal and Unconstitutional Termination of Critical Research Grants
Lieff Cabraser & Farella Braun + Martel Announce That University of California Researchers Have Filed a Class Action Lawsuit Against the Trump Administration for the Illegal and Unconstitutional Termination of Critical Research Grants

Business Wire

time3 hours ago

  • Business Wire

Lieff Cabraser & Farella Braun + Martel Announce That University of California Researchers Have Filed a Class Action Lawsuit Against the Trump Administration for the Illegal and Unconstitutional Termination of Critical Research Grants

SAN FRANCISCO--(BUSINESS WIRE)--Lieff Cabraser & Farella Braun + Martel Announce that a group of six University of California faculty and other researchers have filed a class action in federal court against the Trump Administration on behalf of all UC researchers whose previously approved agency grants were terminated pursuant to Executive Orders or other directives of President Trump, as implemented through the Department of Government Efficiency ('DOGE'). University of California Researchers File Class Action Suit Against Trump Administration for Illegal & Unconstitutional Termination of Critical Research Grants Plaintiffs seek a declaration that these grant terminations violate the constitutional principle of separation of powers, the First Amendment guarantee of free speech, and the Fifth Amendment guarantee of due process, as well as statutes that govern agencies' missions and grantmaking and the Administrative Procedure Act. As detailed in the Complaint, these abrupt cancellations of already awarded grants 'ignored or contradicted the purposes for which Congress created the granting agencies and appropriated funds, and dispensed with the regular procedures and due process afforded grantees under the Administrative Procedure Act, in implementing the Trump Administration's political 'cost-cutting' agenda and ideological purity campaign.' According to UC Berkeley Law Dean Erwin Chemerinsky, a leading constitutional law scholar and co-counsel on the case, 'President Trump and DOGE have arbitrarily cut off funding to researchers throughout the University of California system in clear violation of the Constitution and federal laws. There has not been a semblance of due process or compliance with the procedures required by federal statutes and regulations. This has caused great harm to a large number of faculty and other researchers and the UC research enterprise as a whole, with potentially grave consequences to everyone in society who benefits from the research in a myriad of disciplines." As described by Plaintiff Dr. Neeta Thakur, a pulmonary and critical care specialist at UCSF, 'The EPA has abruptly terminated a three-year grant that was supporting research on how wildfire smoke affects the lungs, heart, and brain of all Californians. My colleagues and I at UCSF and UC Berkeley have worked on this important project for two years, and its sudden end — communicated through a simple form letter — puts our progress in danger. This decision disrupts our ongoing work with community-based organizations and stops us from generating life-saving information designed to improve public health and protect the well-being of all Californians, especially those living in at-risk communities.' Plaintiff Jedda Foreman, the Director of the Center for Environmental Learning at the Lawrence Hall of Science at UC Berkeley, explains, 'My team and I at the Lawrence Hall of Science earned NSF grants to make science education more accessible to all learners. Instilling a love of science is critical to envisioning and creating a better future for us all. In one day, we lost two projects, and nearly 75% of our funding, because of terminations by NSF. A week later, NSF terminated yet another one of our projects. These terminations haven't just affected our team, but also our longtime community partners and thousands of students across the United States.' These are just two of hundreds of examples of the damage wrought by the Trump Administration's illegal and unconstitutional terminations. The lawsuit, filed in the U.S. District Court for the Northern District of California in San Francisco, seeks a return to the pre-Trump Administration process of orderly grantmaking that aligns with congressionally authorized purposes, and affords due process to grant-funded researchers. Plaintiffs seek, for themselves and the class of UC researchers who have suffered unlawful grant terminations, an injunction restoring their lost funding, providing them sufficient time to complete the work for which their grants were originally approved, and preventing further illegal grant terminations. Plaintiffs will be filing a motion for a temporary restraining order on June 5, 2025. The case, No. 3:25-cv-4737, is assigned to the Honorable Rita F. Lin. Background on the Lawsuit Each year, researchers in the UC system receive hundreds of millions of dollars in grants from the full spectrum of federal agencies, ranging from the Environmental Protection Agency, to the National Science Foundation, to the National Institutes of Health. These grants fund the production of new knowledge and fuel the development of discoveries that greatly benefit society at large. The grants have also been key to the innovation that has consistently earned the UC system pride of place among research institutions, including first place in the list of universities with the most utility patents. They have also made the UC Berkeley campus the number one ranked public research in institution in the world for nine of the past ten years. Before President Trump took office, federal grantmaking proceeded under the authority of Congress, which appropriated taxpayer funds for specific public purposes. For decades, agencies carried out these statutory directives and observed due process in making, renewing, and (only seldom) terminating grants. They each adhered to their own grant regulations and followed Administrative Procedure Act processes when modifying such regulations. On the rare occasions when agencies terminated grants, they did so pursuant to predictable, regularized processes and terminated grants only for reasons stated in the regulations. All of this changed abruptly on January 20, 2025 (Inauguration Day). After January 20, 2025, Defendants Donald J. Trump and DOGE, through a flurry of Executive Orders and other directives, commanded the Federal Agency Defendants to terminate scores of previously awarded research grants. As the Complaint notes, the 'abrupt, wholesale, and unilateral termination of these grants has violated the Constitution's bedrock principle of separation of powers and its guarantees of freedom of speech and due process; flouted the Impoundment Control Act limits on the Executive's ability to withhold or redirect congressionally appropriated money; ignored statutory requirements that agencies fulfill their substantive missions and fund congressionally specified activities; contravened agency-specific grant-making regulations that cannot by law be revised on an abrupt, unexplained, chaotic basis; and violated the Administrative Procedure Act through this arbitrary, capricious, and ultra vires conduct.' As further detailed in the Complaint, grounds the agencies have offered for such terminations were spurious. In some cases, agency correspondence to grantees asserted that grant termination would reduce public costs and promote government efficiency, although no evidence was provided to support this claim. In other cases, agency communications made it clear that grants were being terminated to further Defendant Trump's political objectives, which included the elimination of research on climate, environmental justice, 'gender ideology,' and 'DEI.' These grant terminations are occurring not because the grant-funded research departed from its originally approved purpose, but because that purpose now offends the political agenda and ideological requirements of the Trump Administration. In terminating these grants, the agencies have violated the Constitution, numerous federal statutes, and their own regulations. Plaintiff UC researchers have suffered concrete financial, professional, and other harms from Defendants' unilateral termination of grants for projects to which they have already dedicated time and effort; for research upon which they have staked careers and reputations; and for work with research teams through which they endeavored to train a next generation. These terminations have impaired and will impair the public-serving research mission of the UC system and the concern for public welfare that undergirds it. Named Plaintiffs and the Proposed Class will continue to suffer such harms on an ongoing basis, and will experience increasing and irreparable harm absent the court declaration and injunction they seek through this lawsuit.

CDC warns of deadly disease outbreak in key cruise ports
CDC warns of deadly disease outbreak in key cruise ports

Miami Herald

time4 hours ago

  • Miami Herald

CDC warns of deadly disease outbreak in key cruise ports

Before you travel, it's always a good idea to review country-specific health information provided by the Centers for Disease Control and Prevention (CDC), as well as travel safety information provided by the U.S. State Department. These notices and travel advisories provide important information to help U.S. citizens guard their health and safety while traveling abroad - whether on a cruise or another type of trip. Related: US changes travel threat level for controversial Caribbean port Although travelers often focus more attention on destination-specific safety and security threats outlined in travel advisories, it's important to consider travel health notices, too. The CDC recently updated some of these notices, including a vital warning for travelers concerning outbreaks of dengue, a common mosquito-borne disease that can have life-threatening health consequences in some cases. More than 13 million cases of dengue were reported across the Americas and in the Caribbean in 2024, and dengue outbreaks in these areas continue in 2025. Sign up for the Come Cruise With Me newsletter to save money on your next (or your first) cruise. The CDC recently updated its travel health notice about global dengue, warning travelers that a number of countries around the world continue to report increased numbers of cases of the serious disease. In its notice, the CDC also explains that health officials are seeing a concerning rise in the number of dengue cases among U.S. travelers returning from certain countries. Dengue outbreaks are reported regularly in many popular tourist destinations, including cruise ports, in the Caribbean, Central America, South America, Southeast Asia, and the Pacific Islands. Related: Royal Caribbean shares new health warning for cruisepassengers Specific countries currently experiencing dengue outbreaks include: BrazilColombiaComorosCubaEcuador, including the Galápagos IslandsFijiFrench Polynesia, including the island groups of Society Islands (Tahiti, Moorea, and Bora-Bora)Marquesas Islands (Hiva Oa and Ua Huka)Austral Islands (Tubuai and Rurutu)GuadeloupeGuatemalaIranMexicoPakistanPanamaPhilippinesSaint LuciaSamoaSudan, and Tonga. Public health officials in Puerto Rico and the U.S. Virgin Islands have also declared dengue outbreaks. If you're taking a cruise to Puerto Rico, the Virgin Islands, Mexico, Panama, or Saint Lucia, you should be especially careful and take steps to protect yourself from dengue. Be the first to see the best deals on cruises, special sailings, and more. Sign up for the Come Cruise With Me newsletter. Dengue is caused by a virus that's spread by mosquito bites, so the CDC advises travelers visiting risk areas to be diligent about preventing them. The CDC's recommendations for mosquito bite prevention include: Use an Environmental Protection Agency (EPA)-registered insect repellentWear long-sleeved shirts and long pants when outdoorsSleep in an air-conditioned room or room with window screens If you do get mosquito bites during a cruise or other trip to a destination with a dengue risk, there are a few things to know and key symptoms to look out for following your trip. Dengue can take up to two weeks to begin, and illness generally lasts less than a week. Symptoms include fever, headache, nausea, vomiting, rash, muscle and joint pain, and minor bleeding. If you develop a fever or experience other symptoms of dengue, you should see a health care provider and inform them of your travel. Related: CDC says throw this food out after salmonella sickens cruisers In some cases, dengue can become severe within a few hours, quickly turning into a medical emergency that typically requires hospitalization. Severe dengue can lead to hemorrhage (uncontrolled bleeding), shock (seriously low blood pressure), organ failure, and even death. Even if you don't get sick, if you've recently visited a dengue risk area, you should also continue protect yourself from mosquito bites upon your return home to reduce the chance of spreading dengue. The CDC advises that travelers returning from a destination with a dengue risk should take steps to prevent mosquito bites for three weeks in order to avoid spreading dengue to mosquitoes that could spread the virus to other people. (The Arena Group will earn a commission if you book a cruise.) Make a free appointment with Come Cruise With Me's Travel Agent Partner, Postcard Travel, or email Amy Post at amypost@ or call or text her at 386-383-2472. Copyright 2025 The Arena Group, Inc. All Rights Reserved

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store